Conduritol B epoxide

Product Description

Conduritol B Epoxide

Application Notes

In vitro exposure of cells to CBE has been reported to lead to up-regulation of CD1d (cluster of differentiation 1d) expression by THP-1 cells, which is related to an increase in mRNA expression. Has been employed in in vitro and animal models for Gaucher's disease. Treatment of murine peritoneal macrophages with this inhibitor does not seem to affect lysozyme enzyme release to the medium, cell viability, or levels of intracellular lysosomal enzymes, other than & beta-glucosidase activity.

Usage Statement

Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.

Key Applications

Enzymes | Inhibitors | Substrates

Specifications

SKU	02158893-CF
Alternate Names	DL -1,2-Anhydro-myo-inositol; CBE
Application Notes	In vitro exposure of cells to CBE has been reported to lead to up-regulation of CD1d (cluster of differentiation 1d) expression by THP-1 cells, which is related to an increase in mRNA expression. Has been employed in in vitro and animal models for Gaucher's disease. Treatment of murine peritoneal macrophages with this inhibitor does not seem to affect lysozyme enzyme release to the medium, cell viability, or levels of intracellular lysosomal enzymes, other than & beta-glucosidase activity.
Base Catalog Number	158893
Biochemical Physiological Actions	β-Glucosidase inhibitor.
CAS #	6090-95-5
Format	Powder
Molecular Formula	C6H10O5
Molecular Weight	162.141 g/mol
Personal Protective Equipment	Eyeshields, Gloves, Respirator filter
Purity	≥97%
Refractive Index	n20D 1.73(Lit.)
Usage Statement	Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.